Blood Cancer Awareness Month
Advertisement
Dasatinib Plus Venetoclax Effective, Safe for Chronic Phase CML
Andrew MorenoHematology | September 4, 2024
A phase II trial calculated a 4-year event-free survival rate of 96% and overall survival rate of 100% from the combination.
Read More
Database Study Uncovers Thalassemia Mortality Disparities in US Population
Andrew MorenoThalassemia | September 4, 2024
Differences were identified between patient racial groups and by urban versus rural populations.
Read More
Cardiac, Tissue Iron Differences Detected Between Thalassemia Intermedia, Major
Andrew MorenoThalassemia | September 4, 2024
A magnetic resonance imaging study has compared tissue iron levels and biventricular function between the two conditions.
Read More
Advertisement
Advertisement
Latest News

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

April 25, 2025

2025 Hume Award Winner Is Dedicated to Children’s Care

April 25, 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

April 24, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |